Predictors of end stage lung disease in a cohort of patients with scleroderma
about
Functional, radiological and biological markers of alveolitis and infections of the lower respiratory tract in patients with systemic sclerosisManagement of Systemic-Sclerosis-Associated Interstitial Lung DiseaseA methodology for exploring biomarker--phenotype associations: application to flow cytometry data and systemic sclerosis clinical manifestationsScleroderma lung diseasePredictors of interstitial lung disease in early systemic sclerosis: a prospective longitudinal study of the GENISOS cohortAssociation of Interferon- and transforming growth factor β-regulated genes and macrophage activation with systemic sclerosis-related progressive lung fibrosis.Submaximal exercise testing in the assessment of interstitial lung disease secondary to systemic sclerosis: reproducibility and correlations of the 6-min walk testThe current state of biomarkers in systemic sclerosisFibrosing alveolitis in systemic sclerosis: the need for early screening and treatment.The degree of skin involvement identifies distinct lung disease outcomes and survival in systemic sclerosis.Pulmonary involvement in systemic sclerosis: A clinical profile.Exercise peripheral oxygen saturation (SpO2) accurately reflects arterial oxygen saturation (SaO2) and predicts mortality in systemic sclerosis.Changes in plasma CXCL4 levels are associated with improvements in lung function in patients receiving immunosuppressive therapy for systemic sclerosis-related interstitial lung disease.Circulating biomarkers of interstitial lung disease in systemic sclerosis.Interstitial lung disease in systemic sclerosis: current and future treatment.Treatment of Systemic Sclerosis-related Interstitial Lung Disease: A Review of Existing and Emerging Therapies.Predictive value of serial high-resolution computed tomography analyses and concurrent lung function tests in systemic sclerosis.Changes in forced vital capacity over time in systemic sclerosis: application of group-based trajectory modelling.Predictors of end stage lung disease in systemic sclerosis.Incidence of lung cancer in patients with systemic sclerosis treated with extracorporeal photopheresis.Rituximab treatment in patients with systemic sclerosis and interstitial lung disease.Systemic sclerosis associated interstitial lung disease - individualized immunosuppressive therapy and course of lung function: results of the EUSTAR group.
P2860
Q24814170-EAF16D4E-4CBC-407A-A78D-154385600B7FQ26799573-1D93F838-7EB4-4D27-B47C-DB5D3D441C2EQ30993697-DCD87AE3-6AA0-48BD-B98F-58B4526F5342Q33919119-AE8FA16F-53BF-4843-9F92-5EC047C0C952Q34346178-63FBEBD4-144E-47C7-BA05-8C6B0F6378ADQ35628723-B15F8E10-B4DF-40C3-A979-8358D7E1C23DQ35638700-F412408B-E1D8-4C48-9FDF-35EA55763CEDQ35896754-B2CAC5BA-11D3-49D7-BB1E-BBF663AF9962Q35951868-D3632482-73B3-4D2C-81A4-BCD1441AD32EQ36645934-DBDB2846-4EB5-4EED-8C0D-0807509555CCQ36701466-B2B47503-00D2-4D1F-8D0B-966FDD137FB6Q36888217-B0F06317-1520-4C88-ACAC-2F091E1B5173Q37547111-B461031D-A5E5-47B6-81C2-179B33AD85BBQ38044387-B66021C1-DC5D-4F3D-A31C-E0C8446C754EQ38773637-117DF9CF-2070-4900-9F09-4091A5B1B676Q38936954-46C42ED4-55B1-424B-806A-7D37FB4FB7E4Q41009192-B1663CB8-F606-4009-B77D-91F8A45E30B1Q41199736-C18E5A5D-3985-4F3F-8FD3-B06CB13EB21FQ41996144-E584CF9B-DCE9-4029-BE06-5B269BE30656Q44223802-38E95601-AD93-440A-A621-1AB2A770B4D0Q47107441-B2B70D47-B60D-4D18-A2A5-CF8C24EB021BQ49166002-DDAB5A9E-28E1-40CC-93C5-29A95312B2FC
P2860
Predictors of end stage lung disease in a cohort of patients with scleroderma
description
2003 nî lūn-bûn
@nan
2003 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Predictors of end stage lung disease in a cohort of patients with scleroderma
@ast
Predictors of end stage lung disease in a cohort of patients with scleroderma
@en
type
label
Predictors of end stage lung disease in a cohort of patients with scleroderma
@ast
Predictors of end stage lung disease in a cohort of patients with scleroderma
@en
prefLabel
Predictors of end stage lung disease in a cohort of patients with scleroderma
@ast
Predictors of end stage lung disease in a cohort of patients with scleroderma
@en
P2093
P2860
P356
P1476
Predictors of end stage lung disease in a cohort of patients with scleroderma
@en
P2093
P2860
P304
P356
10.1136/ARD.62.2.146
P407
P577
2003-02-01T00:00:00Z